Contain the active ingredient : Glipizide, which is a type of medicine called a sulphonylurea. (NB: glipizide is also available without a brand name, ie as the generic medicine.) Glipizide is used to help control blood sugar levels in people with type 2 diabetes.
People with type 2 diabetes (non-insulin dependent diabetes) have a deficiency of a hormone called insulin. Insulin is produced by the pancreas and is the main hormone responsible for controlling sugar levels in the blood. It normally makes the cells of the body remove excess sugar from the blood. In type 2 diabetes insulin is produced inefficiently in response to surges of blood sugar, eg following a meal. The cells of the body also become resistant to the action of insulin that is produced, which means that blood sugar levels can become too high.
Glipizide works mainly by stimulating the cells in the pancreas that produce insulin. These cells are called beta cells. Glipizide causes the beta cells to produce more insulin. This helps to decrease the amount of sugar in the blood of people with type 2 diabetes.
Glipizide also increases the uptake of sugar from the blood into muscle and fat cells and decreases the production of sugar by the liver.
Glipizide is a first line option for treating type 2 diabetes in people who are not overweight, or who cannot take metformin. It is used when diet and exercise have failed to control blood sugar levels. It can also be used in combination with other antidiabetic medicines to provide better control of blood sugar.
All these actions help to decrease the amount of sugar in the blood of people with type 2 diabetes.
Minodiab tablets should normally be taken before breakfast or the first main meal of the day.
What is it used for?
Type 2 diabetes, when diet has failed to fully control blood sugar.
Size : 30 tablets/box